The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...
SCD is an inherited blood disorder that affects millions of children worldwide, particularly in India and sub-Saharan Africa, ...
A Gurugram hospital study reveals significant success in curing Sickle Cell Disease among children through bone marrow ...
Gurugram, have achieved a milestone in treating children with sickle cell disease (SCD) through bone marrow (stem cell) ...
Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment ...
GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.
Health Ministry Asks NMC to Review Uniform Stipend for MBBS Interns in Govt and Private CollegesThe long-pending issue of ...
Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...
Disc Medicine will be enrolling 24 adults with SCD in its newly launched trial testing DISC-3405 at three doses for easing ...
Intellia faces FDA clinical holds on key ATTR studies as it readies crucial HAE data in 2026, making lonvo-z pivotal for its near-term outlook.
The Punch on MSN
Why parents with AA genotype can’t have AS children — Doctors
Public Health experts have asserted that reports of AA-genotype parents having an AS child are always linked to laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback